BIOMAT Database Logo BIOMAT Database Logo

Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma. 1980

G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008228 Lymphoma, Non-Hodgkin Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. Non-Hodgkin Lymphoma,Diffuse Mixed Small and Large Cell Lymphoma,Diffuse Mixed-Cell Lymphoma,Diffuse Small Cleaved-Cell Lymphoma,Diffuse Undifferentiated Lymphoma,Lymphatic Sarcoma,Lymphoma, Atypical Diffuse Small Lymphoid,Lymphoma, Diffuse,Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic,Lymphoma, High-Grade,Lymphoma, Intermediate-Grade,Lymphoma, Low-Grade,Lymphoma, Mixed,Lymphoma, Mixed Cell, Diffuse,Lymphoma, Mixed Lymphocytic-Histiocytic,Lymphoma, Mixed Small and Large Cell, Diffuse,Lymphoma, Mixed-Cell,Lymphoma, Mixed-Cell, Diffuse,Lymphoma, Non-Hodgkin's,Lymphoma, Non-Hodgkin, Familial,Lymphoma, Non-Hodgkins,Lymphoma, Nonhodgkin's,Lymphoma, Nonhodgkins,Lymphoma, Pleomorphic,Lymphoma, Small Cleaved Cell, Diffuse,Lymphoma, Small Cleaved-Cell, Diffuse,Lymphoma, Small Non-Cleaved-Cell,Lymphoma, Small Noncleaved-Cell,Lymphoma, Small and Large Cleaved-Cell, Diffuse,Lymphoma, Undifferentiated,Lymphoma, Undifferentiated, Diffuse,Lymphosarcoma,Mixed Small and Large Cell Lymphoma, Diffuse,Mixed-Cell Lymphoma,Mixed-Cell Lymphoma, Diffuse,Non-Hodgkin's Lymphoma,Reticulosarcoma,Reticulum Cell Sarcoma,Reticulum-Cell Sarcoma,Sarcoma, Lymphatic,Sarcoma, Reticulum-Cell,Small Cleaved-Cell Lymphoma, Diffuse,Small Non-Cleaved-Cell Lymphoma,Small Noncleaved-Cell Lymphoma,Undifferentiated Lymphoma,Diffuse Lymphoma,Diffuse Lymphomas,Diffuse Mixed Cell Lymphoma,Diffuse Mixed-Cell Lymphomas,Diffuse Small Cleaved Cell Lymphoma,Diffuse Undifferentiated Lymphomas,High-Grade Lymphoma,High-Grade Lymphomas,Intermediate-Grade Lymphoma,Intermediate-Grade Lymphomas,Low-Grade Lymphoma,Low-Grade Lymphomas,Lymphatic Sarcomas,Lymphocytic-Histiocytic Lymphoma, Mixed,Lymphocytic-Histiocytic Lymphomas, Mixed,Lymphoma, Diffuse Mixed-Cell,Lymphoma, Diffuse Undifferentiated,Lymphoma, High Grade,Lymphoma, Intermediate Grade,Lymphoma, Low Grade,Lymphoma, Mixed Cell,Lymphoma, Mixed Lymphocytic Histiocytic,Lymphoma, Non Hodgkin,Lymphoma, Non Hodgkin's,Lymphoma, Non Hodgkins,Lymphoma, Nonhodgkin,Lymphoma, Small Non Cleaved Cell,Lymphoma, Small Noncleaved Cell,Lymphosarcomas,Mixed Cell Lymphoma,Mixed Cell Lymphoma, Diffuse,Mixed Lymphocytic-Histiocytic Lymphoma,Mixed Lymphocytic-Histiocytic Lymphomas,Mixed Lymphoma,Mixed Lymphomas,Mixed-Cell Lymphomas,Non Hodgkin Lymphoma,Non Hodgkin's Lymphoma,Non-Cleaved-Cell Lymphoma, Small,Non-Hodgkins Lymphoma,Noncleaved-Cell Lymphoma, Small,Nonhodgkin's Lymphoma,Nonhodgkins Lymphoma,Pleomorphic Lymphoma,Pleomorphic Lymphomas,Reticulosarcomas,Reticulum Cell Sarcomas,Reticulum-Cell Sarcomas,Sarcoma, Reticulum Cell,Small Cleaved Cell Lymphoma, Diffuse,Small Non Cleaved Cell Lymphoma,Small Non-Cleaved-Cell Lymphomas,Small Noncleaved Cell Lymphoma,Small Noncleaved-Cell Lymphomas,Undifferentiated Lymphoma, Diffuse,Undifferentiated Lymphomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009279 Naphthacenes Polyacenes with four ortho-fused benzene rings in a straight linear arrangement. This group is best known for the subclass called TETRACYCLINES. Tetracenes,Benz(b)Anthracenes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase II trial of aclacinomycin A in acute leukemia and various solid tumors.
January 1983, Journal of cancer research and clinical oncology,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
A phase II study of aclacinomycin A in acute leukemia in adults.
December 1980, Cancer treatment reviews,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
January 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.
January 1978, Cancer chemotherapy and pharmacology,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase I-II trial of mitoxantrone in acute leukemia.
January 1985, Cancer treatment reports,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase II trial of mitoxantrone in refractory acute leukemia.
April 1983, Cancer treatment reports,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase II trial of vincristine infusion in acute leukemia.
January 1985, Cancer chemotherapy and pharmacology,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase I trial of aclacinomycin A.
May 1982, Cancer treatment reports,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase II trial of plicamycin and hydroxyurea in acute myelogenous leukemia.
January 1989, Cancer chemotherapy and pharmacology,
G Mathé, and M A Gil, and M Delgado, and M Bayssas, and J Gouveia, and P Ribaud, and D Machover, and J L Misset, and F de Vassal, and L Schwarzenberg, and C Jasmin, and M Hayat
Phase II trial of vindesine in patients with acute leukemia.
January 1979, Cancer treatment reports,
Copied contents to your clipboard!